A study in The Lancet has found that young people diagnosed with HIV in the US and Europe now have a near normal life expectancy because of improvements in drug treatments.
A study in The Lancet has found that young people diagnosed with HIV in the US and Europe now have a near normal life expectancy because of improvements in drug treatments.
Results of new modelling research published in The Lancet HIV journal show that offering PrEP with regular HIV testing, and early treatment to just a quarter of Men who have sex with men (MSM) at high risk of contracting HIV could prevent around 7,400 new HIV infections (44 per cent of total incidence) in the UK before 2020.
